CCK-B Receptor Antagonist 1 (Synonyms: (Rac)-Netazepide; (Rac)-YF 476; (Rac)-YM-220) |
Katalog-Nr.GC30752 |
CCK-B-Rezeptorantagonist 1 ist ein Antagonist des Cholecystokinin B (CCK-B)-Rezeptors und hat das Potenzial, die Sekretion von MagensÄure zu reduzieren.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 168161-71-5
Sample solution is provided at 25 µL, 10mM.
CCK-B Receptor Antagonist 1 is an antagonist of cholecystokinin B (CCK-B) receptor, and has the potential of reducing the secretion of gastric acid.
CCK-B Receptor Antagonist 1 is an antagonist of CCK-B receptor, and has the potential of reducing the secretion of gastric acid[1].
[1]. Hamish Ryder, et al. Benzodiazepin derivatives useful as cck-receptor antagonists. WO 1993016999 A1.
Average Rating: 5
(Based on Reviews and 27 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *